Achieve Life Sciences
ACHV
35 hedge funds and large institutions have $13.4M invested in Achieve Life Sciences in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 8 closing their positions.
2.22% less ownership
Funds ownership: 16.99% → 14.77% (-2.2%)
10% less funds holding
Funds holding: 39 → 35 (-4)
28% less capital invested
Capital invested by funds: $18.6M → $13.4M (-$5.17M)
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
38% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 13
56% less call options, than puts
Call options by funds: $111K | Put options by funds: $252K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$119K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$114K |
| 3 |
LPL Financial
San Diego,
California
|
+$83.2K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$81.5K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$56.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$1.12M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$477K |
| 3 |
SC
Shay Capital
New York
|
-$179K |
| 4 |
Walleye Capital
New York
|
-$128K |
| 5 |
Renaissance Technologies
New York
|
-$88.2K |
ACHV Hedge Fund Activity: Q3 2023 in Review
35 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q3 2023, worth a combined $13.4M — down 28% from $18.6M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ACHV and 5 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 8 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $119K. The largest seller was B. Riley Wealth Advisors, exiting entirely with an estimated $1.12M sold.
- 35 institutional investors held Achieve Life Sciences (ACHV) as of Q3 2023, down from 39 in Q2 2023.
- Funds reported $13.4M of Achieve Life Sciences stock for Q3 2023, down 28% quarter-over-quarter.
- 5 funds opened new Achieve Life Sciences positions in Q3 2023 and 8 closed out, a net change of -3 holders.
- The largest Achieve Life Sciences buyer in Q3 2023 was Millennium Management, an estimated $119K added.
- The largest Achieve Life Sciences seller in Q3 2023 was B. Riley Wealth Advisors, an estimated $1.12M sold.
Based on aggregated 13F filings for Q3 2023.